What are the top 3 stocks to buy now?

1. Aptose Biosciences (NASDAQ:APTO) is a clinical-stage biotechnology company specializing in the development of personalized treatments for life-threatening cancers. Today, analyst Joseph Pantginis of HC Wainwright maintained a Buy recommendation for the stock with a target price of $23. Overall, the agreed-upon 12-month target price of all four of the top analysts who recently gave the stock a Buy suggests a huge upside potential of 385.61%.

2. General Motors (NYSE:GM) - General Motors is an American multinational automobile company. On Friday, RBC Capital analyst Tom Narayan reaffirmed his Buy recommendation for the stock. Overall, the agreed 12-month price target for five of the top six analysts who recently gave the stock a Buy suggests upside potential of nearly 31%.

3. Celldex (NASDAQ:CLDX) is a clinical-stage biotechnology company developing treatments for inflammatory, autoimmune, and cancer-related diseases. Today, analyst Joseph Pantginis of HC Wainwright maintained his Buy recommendation on the stock with a target price of $65. Overall, the agreed-upon 12-month price target for all four of the top analysts who recently gave the stock a Buy suggests 83.9% upside potential.